Andrea DiFabio
CIK 1692506 · Chief Legal Officer · last filed 2026-03-13
Andrea DiFabio is a Chief Legal Officer who has filed 15 SEC Form 4 insider transactions across 2 companies since 2017. The most recent filing, for XENE, was dated Mar 13, 2026. Across all open-market trades the lifetime net is −$230.8K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $450.3K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$450.3K
2
15
-$230.8K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| XENE | Chief Legal Officer | 8,643 | $52.10 | $450.3K | -$230.8K | 7 | 2026-03-13 |
| Bioverativ Inc. (BIVV) Delisted | EVP, Chief Legal Officer | 0 | — | — | $0 | 8 | 2018-03-08 |
Recent Filings
15 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-13 | XENE | Mixed | +2,408 | -$74.1K | EDGAR |
| 2026-03-11 | XENE | Mixed | +4,893 | -$156.7K | EDGAR |
| 2026-01-09 | XENE | Grant (A) | — | $0 | EDGAR |
| 2025-03-13 | XENE | Grant (A) | — | $0 | EDGAR |
| 2024-03-12 | XENE | Grant (A) | — | $0 | EDGAR |
| 2023-03-14 | XENE | Grant (A) | — | $0 | EDGAR |
| 2022-11-09 | XENE | Grant (A) | — | $0 | EDGAR |
| 2018-03-08 | Bioverativ Inc. (BIVV) Delisted | Disp (D) | −30,600 | $0 | EDGAR |
| 2018-02-26 | Bioverativ Inc. (BIVV) Delisted | Tax (F) | −2,928 | -$305.8K | EDGAR |
| 2018-02-15 | Bioverativ Inc. (BIVV) Delisted | Mixed | +2,608 | -$117.6K | EDGAR |